ClinicalTrials.govpublic full text
Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles
coronary artery disease, atherosclerosis, inflammation, inflamation, nanoparticles, paclitaxel, drug targeting, drug delivery system, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871930
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.